U.S. flag An official website of the United States government
  1. Home
  2. Training and Continuing Education
  3. CDERLearn Training and Education
  1. Training and Continuing Education

CDERLearn Training and Education

Learning opportunities for healthcare professionals, academia, students, and consumers

Search General Courses   Search Industry Courses

Upcoming Free CE Opportunities

CDERLearn
 

Use filters and search box to find resources

Advanced search (combine topic and search terms)

Summary Type Topic

COVID-19 Health Care Professional Resources

Health Care Professionals; Patients; Podcasts; Videos COVID-19; Disease States; Drug Regulatory Process; Drug Development; Drug Safety; MedWatch
FDA’s Overdose Prevention Framework with Dr. Marta Sokolowska Health Care Professionals; Patients; Podcasts Disease States; Drug Regulatory Process; Drug Development; Drug Safety; MedWatch; Opioids; Cancer Drugs
FDA Health Playbook Health Care Professionals; Patients; Videos; Graphics; Podcasts; Social Media Drug Safety; OTC Drug Regulations; MedWatch; Opioids
COVID-19 Evidence Accelerator: What We've Learned, Where We're Headed Health Care Professionals; Patients; Webinars COVID-19; Disease States; Drug Regulatory Process; Drug Development; Drug Safety
14th Annual Sentinel Initiative Public Workshop Health Care Professionals; Patients; Webinars COVID-19; Disease States; Drug Regulatory Process; Drug Development; Drug Safety
Medical Extended Reality: Applications and Challenges Health Care Professionals; Patients; Webinars Disease States; Drug Regulatory Process; Drug Development; Drug Safety

Highlights in Oncofertility: Trends in an Emerging Field for Cancer Survivors

Health Care Professionals; Patients; Webinars Cancer Drugs; Disease States; Drug Regulatory Process; Drug Development; Drug Safety; Women’s Health
What does FDA regulate? Health Care Professionals; Patients; Videos; Graphics Disease States; Drug Regulatory Process; Drug Development; Drug Safety; Generic Drugs; OTC Drug Regulations; Women’s Health
FDA Grand Rounds Health Care Professionals; Patients; Webinars COVID-19; Disease States; Drug Regulatory Process; Drug Development; Drug Safety; MedWatch; Generic Drugs; OTC Drug Regulations; Biosimilars; IND; Cancer Drugs; Biomarker; Women’s Health
Safe Opioid Disposal Safe Opioid Disposal - Remove the Risk Outreach Toolkit Disease States; Drug Regulatory Process; Drug Development; Drug Safety; MedWatch; Generic Drugs; Cancer Drugs; Opioids
What Does FDA Do? Health Care Professionals; Patients; Videos Disease States; Drug Regulatory Process; Drug Development; Drug Safety; MedWatch; Generic Drugs; OTC Drug Regulations; IND; Women’s Health

COVID-19 Evidence Accelerator: What We've Learned, Where We're Headed

Type: Health Care Professionals; Patients; Videos Topic: COVID-19; Disease States; Drug Regulatory Process; Drug Development; Drug Safety; IND; Cancer Drugs
Conversation on Paxlovid with Dr. John Farley Health Care Professionals; Patients; Podcasts COVID-19; Disease States; Drug Regulatory Process; Drug Development; Drug Safety
Clinical Trial Basics with Dr. Robert Temple Health Care Professionals; Patients; Podcasts Disease States; Drug Regulatory Process; Drug Development; Drug Safety; IND; Biomarker; Women’s Health
Biosimilars Patient Materials Graphics; Videos; Patients Biosimilars; Drug Regulatory Process; Drug Development; Disease States; Drug Safety
Clinical Trial Basics Health Care Professionals; Podcasts Biomarkers; Disease States; Drug Regulatory Process; Drug Development; Drug Safety; IND; Women’s Health
Adverse Events Associated with Compounded Drugs from Outsourcing Facilities Health Care Professionals; Case Study; Podcasts; Videos; Webinars Compounding; Disease States; Drug Development; Drug Regulatory Process; Drug Safety; MedWatch
Biosimilars 101: A Primer for Your Practice CE Credits; Health Care Professionals; Case Study Biosimilars; Cancer Drugs; Diabetes; Disease States; Drug Regulatory Process; Drug Development; Drug Safety; Generic Drugs; MedWatch; Women’s Health
Incorporating Biosimilars Into the Management of Patients With Immunological Conditions CE Credits; Health Care Professionals; Case Study Biosimilars; Cancer Drugs; Diabetes; Disease States; Drug Regulatory Process; Drug Development; Drug Safety; Generic Drugs; MedWatch; Women’s Health
Putting the Patient into Perspective: Strategies for Educating Patients about Biosimilars CE Credits; Health Care Professionals; Case Study; Podcasts; Videos; Webinars Biosimilars; Cancer Drugs; Diabetes; Disease States; Drug Regulatory Process; Drug Development; Drug Safety; Generic Drugs; MedWatch; Women’s Health
Biosimilars Resources Health Care Professionals; Case Study; Podcasts; Videos; Webinars Biosimilars; Drug Regulatory Process; Drug Development
Bridging Efficacy and Safety to the Obese Health Care Professionals; Webinars Biomarker; Cancer Drugs; Diabetes; Disease States; Drug Development; Drug Regulatory Process; Drug Safety; Generic Drugs; IND; MedWatch; Women's Health
Engaging Providers to Address Knowledge Gaps on Medication Use in Pregnancy and Lactation CE Credits; Health Care Professionals; Webinars Disease States; Drug Development; Drug Regulatory Process; Drug Safety; Generic Drugs; MedWatch; Women's Health
Biosimilars Videos Healthcare Professionals; Videos Biosimilars; Drug Regulatory Process Drug Development
Biosimilars Level 2: Regulatory and Scientific Concepts Case Study Health Care Professionals
Biosimilars Level 1: Foundational Concepts Case Study Health Care Professionals
Increasing the Efficiency of Biosimilar Development Programs Health Care Professionals; Webinars Biosimilars; Drug Regulatory Process; Drug Development
Successfully Navigating the USPTO and FDA CE Credits; Webinars Drug Development; Drug Regulatory Process; Drug Safety; Registration and Listing
The History of FDA Health Care Professionals; Webinars Drug Development; Drug Regulatory Process; Drug Safety
Bench to Bedside: Integrating Sex and Gender to Improve Human Health CE Credits; Health Care Professionals; Webinars Diabetes; Disease States; Drug Development; Drug Regulatory Process; Drug Safety; Women's Health
Q&A with FDA Health Care Professionals; Podcasts COVID-19; Disease States; Drug Regulatory Process; Drug Development; Drug Safety; MedWatch
Biosimilars Level 1: Foundational Concepts Health Care Professionals; Case Study Biosimilars; Drug Regulatory Process; Drug Development
Biosimilars Level 2: Regulatory and Scientific Concepts Health Care Professionals; Case Study Biosimilars; Drug Regulatory Process; Drug Development
Biosimilars Curriculum Materials Health Care Professionals; Case Study; Podcasts; Videos; Webinars Biosimilars; Drug Regulatory Process; Drug Development
Drug Approval Case Studies Health Care Professionals Drug Regulatory Process
FDA’s Role in Public Health: Drug Efficacy, Safety, Quality, and Beyond Health Care Professionals; CE Credits Drug Regulatory Process
Practitioners’ Guide for Improving Oral Anticoagulant Use Health Care Professionals; CE Credits Oral Anticoagulant; Disease States
The FDA Bad Ad Program and Prescription Drug Promotion Health Care Professionals; CE Credits Prescription Drug Promotion
FDA MedWatch and Patient Safety Health Care Professionals MedWatch; Drug Safety
The FDA Process for Approving Generic Drugs Health Care Professionals Drug Regulatory Process; Drug Development; Generic Drugs
FDA Overview of Biosimilar Products Health Care Professionals; Videos Biosimilars; Drug Regulatory Process; Drug Development
Leveraging Health Literacy and Patient Preferences to Reduce Hypoglycemia Events in Patients with Type 2 Diabetes Health Care Professionals Diabetes; Disease States
Director's Corner Podcasts Health Care Professionals; Podcasts Drug Regulatory Process; Drug Development; Compounding; Generic Drugs; Drug Safety; MedWatch; Disease States
Drug Information Soundcast in Clinical Oncology (D.I.S.C.O) Health Care Professionals; Podcasts Cancer Drugs; Disease States; Drug Regulatory Process; Drug Development; Drug Safety; Generic Drugs; MedWatch; Women’s Health
FDA Drug Safety Podcasts Health Care Professionals; Podcasts Drug Safety; Biosimilars; Cancer Drugs; Diabetes; Disease States; Drug Regulatory Process; Drug Development; Drug Safety; Generic Drugs; MedWatch; Women’s Health
Regulatory Science at CDER Podcasts Health Care Professionals; Podcasts Drug Development; Disease States; Drug Regulatory Process; Drug Safety; IND
FDA's Biomarker Qualification Program Videos Biomarker; Drug Development
Biosimillars Health Care Provider Materials Health Care Professionals; Videos; Graphics; Social Media Biosimilars; Drug Regulatory Process; Drug Development; Disease States; Drug Safety
FDA Drug Info Rounds Health Care Professionals; Videos Drug Safety; MedWatch; IND; Drug Development; Drug Regulatory Process; Prescription Drug Promotion; Disease States; Registration and Listing; Generic Drugs
GDUFA II Videos and Resources Videos Drug Development; Generic Drugs
Regulatory Science at CDER Videos Videos Drug Regulatory Process; Drug Development
Biosimilars Online Courses, Webinars, and Presentations Health Care Professionals; Webinars Biosimliars; Drug Regulatory Process; Drug Development
CDER Webinars Health Care Professionals; Webinars Drug Regulatory Process; Drug Development; Generic Drugs; OTC Drug Regulations; Registration and Listing; Electronic Submissions; Biosimilars; Drug Safety; MedWatch; IND; Disease States; Prescription Drug Promotion; Cancer Drugs
Division of Drug Information Webinars Health Care Professionals; Webinars; CE Credits Drug Regulatory Process; Drug Development; Generic Drugs; OTC Drug Regulations; Biosimilars; Drug Safety; MedWatch; IND; Disease States; Prescription Drug Promotion; Cancer Drugs
Compounding Quality Center of Excellence On-Demand Training CE Credits; Health Care Professionals; Case Study; Podcasts; Videos; Webinars Compounding; Disease States; Drug Development; Drug Regulatory Process; Drug Safety; MedWatch

 

Additional Resources

 

 


Sub-Topic Paragraphs

Paragraph Header
Contact Us

Contact Point
Office of Communications
10001 New Hampshire Ave
Hillandale Building, 4th Fl
Silver Spring, MD 20993

Toll Free
(855) 543-3784
(301) 796-3400

Hours Available

CDER Division of Drug Information

For Updates on Twitter follow

Contact Point Twitter

@FDA_Drug_Info

Your source for the latest drug information.
Know the moment it happens.


Back to Top